J. Eduardo Rame

Louis R. Dinon MD Professor of Medicine, Enterprise Chief

Thomas Jefferson University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. J. Eduardo Rame is the Louis R. Dinon MD Professor of Medicine and Enterprise Chief at Thomas Jefferson University, United States. His research focuses on cardiac health, with recent articles exploring topics such as the hemodynamic effects of anesthesia in patients with left ventricular assist devices, outcomes related to heart transplant donors and recipients, and novel treatment approaches for chronic heart failure. Dr. Rame's contributions to the field also include investigations into the management of coagulopathy in COVID-19 patients undergoing ECMO and predictors of mortality in those weaned from venoarterial extracorporeal membrane oxygenation.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Alexander Fanaroff

Assistant Professor of Medicine

University of Pennsylvania

UNITED STATES

View details

Payman Zamani

Assistant Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

J. Eduardo Rame

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Effect of Anesthesia Induction on Cardiac Hemodynamics in Patients Undergoing Durable Left Ventricular Assist Device Implantation: The EACH-LVAD Study

Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis

Left Ventricular Assist Device as a Bridge to Recovery: Single Center Experience of Successful Device Explantation

A Modified Grading System for Early Right Heart Failure Matches Functional Outcomes and Survival After Left Ventricular Assist Devices

Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation An Analysis of the STS-INTERMACS Registry

Cardio-microcurrent device for chronic heart failure: first-in-human clinical study

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy

Early Usage of Extracorporeal Membrane Oxygenation in the Absence of Invasive Mechanical Ventilation to Treat COVID-19-related Hypoxemic Respiratory Failure

Myocardial Edema Revisited in a New Paradigm of Cardiac Electrical Microcurrent Application in Heart Failure

Predictors of in-hospital mortality and midterm outcomes of patients successfully weaned from venoarterial extracorporeal membrane oxygenation

Collaborators (2)

Alexander Fanaroff

Payman Zamani

Make your next move.